Latest News

Livegenic and Service Certainty Partner to Provide Leading-edge Video Collaboration Solutions

SYDNEY, Jan. 4, 2022 /PRNewswire/ -- Global insurance technology solutions provider Wilbur (https://www.wilbur.io/ ) (parent of Livegenic) has announced a partnership with theUnited Kingdom's largest network of professional photographers, Service Certainty ( https://www.se...

2022-01-04 16:00 2509

Affiliates Flock to Seal Partnerships with Malaysia Healthcare at Expo 2020 Dubai

DUBAI, UAE, Jan. 4, 2022 /PRNewswire/ -- Malaysia's healthcare travel industry led by the Malaysia Healthcare Travel Council (MHTC), welcomed more new partnerships at the Malaysia Pavilion in Expo 2020 Dubai. Memorandums of Understanding (MoUs) were exchanged with renowned players such as Interna...

2022-01-04 15:32 2458

ASEAN Leaders Must See Funding For Sustainability As An Investment Not A Cost, To Achieve Better Trading Opportunities

PETALING JAYA, Malaysia, Jan. 4, 2022 /PRNewswire/ -- For ASEAN to accelerate and meet the requirements by its global partners for greater sustainable trade and commerce, leaders must adopt a mega shift in behaviour and mindset. They must recognise that sustainability will require fundings and it...

2022-01-04 12:54 2687

Xinhua Silk Road: Chery's NEV QQ Ice Cream unveiled at a cultural festival in Wuhu, Anhui

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Chery Automobile has launched its first new energy vehicle (NEV) QQ Ice Cream recently, in light of which Wuhu City of eastChina's Anhui Province held a cultural festival on December 28 to not only introduce the new auto product, but also promote Wuhu's tradi...

2022-01-04 12:39 6746

Shiyu Wang Rejoins Qiming Venture Partners as Partner, Co-Leads TMT Team

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Qiming Venture Partners, a leading venture capital firm inChina, is pleased to announce that Shiyu Wang has rejoined the firm as a Partner.Shiyu Wang will co-lead the TMT team, managing and investing in the internet and consumer sectors. Shiyu Wang has many...

2022-01-04 12:11 3701

CGTN: CMG president delivers New Year message to overseas audience

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Shen Haixiong, president of China Media Group (CMG), extended New Year greetings in an address to overseas audiences via CGTN, China Radio International, and through the internet onJanuary 1, 2022.   CMG President Shen Haixiong said 2021 was...

2022-01-04 11:10 3659

Spreading the wing to enter Taiwan's robotics market to catch up with AMR trend

TAIPEI, Jan. 4, 2022 /PRNewswire/ -- All major robotic manufacturers invested a lot to keep up with the trend of AMR. In the Automation Taipei exhibition, many players have launched their flagship AMR products that drew people's attention.

2022-01-04 10:05 3065

Prudential Singapore boosts support for SMEs in their digitalisation efforts and business growth

SINGAPORE, Jan. 4, 2022  /PRNewswire/ -- Prudential Singapore ("Prudential") has partnered Ngee Ann Polytechnic ("Ngee Ann Poly") and ST Engineering to equip small and medium-sized enterprises (SMEs) with the knowledge and resources on how to go digital in a safe and secure manner.

2022-01-04 10:05 4214

Gaw NP Industrial opens second ready-built-factory as demand soars in Vietnam

THAI NGUYEN, Vietnam, Jan. 4, 2022 /PRNewswire/ -- Gaw NP Industrial (GNP) broke ground onDecember 28, 2021 for its second premium ready-built-factory (RBF) project, the GNP Yen Binh 2 - Industrial Center. GNP Yen Binh 2 is designed to cater to ...

2022-01-04 10:00 8171

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Joint research results from Biologics of Jemincare and Shanghai Institute ofMateria Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002, an anti-SARS-CoV-2 neutralizing antibody (NAb) discovered by Biologics of Jemincare is still effect...

2022-01-04 10:00 5545

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CONCURRENT CHEMORADIOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER

HONG KONG, Jan. 3, 2022 /PRNewswire/ -- Today, Akeso (09926.HK) announces that Cadonilimab (PD-1/ CTLA-4 bi-specific antibody), the first-inclass novel immuno-oncology drug independently developed by the Company, combined with concurrent chemoradiotherapy obtained approval from the Center for Dru...

2022-01-04 10:00 3178

TCI's Golden Formula Has Won the Best Plant-Based Functional Product in the World Plant-Based Awards 2021

TAIPEI, Jan. 3, 2022 /PRNewswire/ -- In recent years, there has been a global trend of plant-based health care, which is known as vegetarian food in Taiwan. In the World Plant-Based Awards, jointly organized by FoodBev Media and Plant Based World Expo & Conference, TCI's Golden Formula won the be...

2022-01-04 09:00 2909

SK Group strengthens its commitment to Malaysia with over $700m investments including Digital Bank and EV

KUALA LUMPUR, Malaysia, Jan. 4, 2022 /PRNewswire/ -- SK Group, the second largest conglomerate in Korea with a market capitalization of$177bn, has committed over$700m investments in Malaysia in 2021, and intends to invest further into the country moving forward. In January 2021, SK Nexilis annou...

2022-01-04 09:00 3676

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH

* ASC43F was safe and well tolerated in healthy subjects with no clinically significant study drug related adverse events * Pharmacokinetic parameters of ASC41 and ASC42 from ASC43F are similar to those of ASC41 and ASC42 monotherapy * Phase I trial completed two months after the U.S. IND ap...

2022-01-04 08:30 4614

­Mirae Asset Scores Four Gongs at Bloomberg Businessweek's Top Fund Awards

HONG KONG, Jan. 4, 2022 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited (the "firm" or "Mirae Asset") today announced that its ETF and mutual fund products won four coveted prizes at Bloomberg Businessweek's (Chinese Edition) Top Fund Awards onDecember 10, 2021. The Global ...

2022-01-04 08:22 3077

Asieris Announces the World's First Patient Dose Administered in Combination of Asieris'APL-1202 and BeiGene's Tislelizumab as Neoadjuvant Therapy for MIBC Patients

SHANGHAI, Jan. 3, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a global innovative pharma company specializing in new drugs for the treatment of genitourinary tumors, today announced that the world's first patient dose has been administered in U.S. for its oral APL-1202 in combination ...

2022-01-04 08:06 2172

Everest Medicines Announces Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan in Second-Line Metastatic Triple-Negative Breast Cancer

SHANGHAI, Jan. 4, 2022 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products inAsia, announced today that T...

2022-01-04 08:00 5311

Buybacks of series B shares in AB Electrolux during week 52, 2021

STOCKHOLM, Jan. 4, 2022 /PRNewswire/ -- During the period December 27 – December 30, 2021 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize...

2022-01-04 02:20 3539

Saudi Conventions and Exhibitions General Authority officially announces Autoville motoring festival in Riyadh

- The Saudi International Festival of Motoring (Autoville) is the first and the largest interactive event of its kind in the region, bringing together more than 100 international brands in the automotive and accessories sector - Extending over an area of 1.7 million square meters, the festival is...

2022-01-04 02:18 3109

Acer Unveils Trio of Chromebooks for Families, Students, and Hybrid Workers

Editor's Summary * The Acer Chromebook Spin 513 (CP513-2H) boosts productivity on-the-go with a sleek, convertible design, 13.5-inch VertiView® display with a 3:2 aspect ratio, long battery life and exceptional performance—powered by the octa-core MediaTek Kompanio 1380 processor * The Acer ...

2022-01-04 01:05 2517